| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212412 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 31 Pages |
Abstract
Elderly HPV+Â OPC patients have longer survival than their HPVâ counterparts. Lower Zubrod scale score and higher radiation therapy dose are associated with longer OS, whereas fewer smoking pack-years and systemic agents have nonsignificant associations. Comorbidity-polypharmacy score, but not CCI, is correlated with OS, especially in HPV+Â patients, suggesting the potential importance of assessing polypharmacy in addition to comorbidity burden in this population.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Francesca MD, Brian MD, Scott V. MD, PhD, Jolie MD, Lin MSc, Andrew MD, John MD, PhD, Meredith MD, Andrew MD, John MD, John MD, Aaron MD, David MD, Bayardo MD, Ilan MD, Li BSc, Yuyao MMath, Wei PhD, Shao Hui MD, MSc, MRT(T),